Market Overview

Actavis, Allergan Could Announce Merger Deal Monday

Related AGN
Barron's Picks And Pans: Allergan, Broadcom, Gap And More
Allergan Considering All Strategic Options 'With A Sense Of Urgency'
The Vetr community has upgraded $AGN to 4.5-Stars. (Vetr)

Actavis PLC (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) are close to a merger deal, according to The Wall Street Journal. The reported price for Allergan is $210 to $220, according to sources.

A deal between the two pharmaceutical companies would make it nearly impossible for Valeant Pharmaceuticals and investor Bill Ackman to takeover the combined company.

The announcement of a merger deal could come as early as Monday, reports persons familiar with the matter.

Actavis closed Friday at $243.77, a gain of $2.14 (0.89 percent), while Allergan shares gained $2.44 (1.24 percent) to close at $198.65.

Posted-In: Wall Street JournalNews Rumors M&A Media


Related Articles (AGN + ACT)

View Comments and Join the Discussion!